![]() Olio Olio operates a collaboration platform that digitally connects hospital and physician teams with post-acute providers around the patient's healthcare episode type. | ![]() Precision BioSciences Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. | ![]() Velabs Therapeutics Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. | ![]() AmacaThera AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications. | ![]() DermBiont DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases. | |
Founding Date | Founding Date 2017 | Founding Date 2006 | Founding Date N/A | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Indianapolis, US HQ | Locations HQ Durham, US | Locations Heidelberg, DE HQ | Locations Toronto, CA HQ Toronto, CA | Locations Boston, US HQ Emeryville, US |
Employees | Employees 826% increase | Employees 1998% increase | Employees N/A | Employees 12 | Employees 215% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 2.5m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 3.4m (almost 7 years ago) | Latest funding round $ 3.6m (over 6 years ago) | Latest funding round $ 8m (almost 7 years ago) |
Total funding raised | Total funding raised $ 2.5m | Total funding raised $ 175.2m | Total funding raised $ 3.4m | Total funding raised $ 6.1m | Total funding raised $ 8m |

Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS.
View company
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.
View company
AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications.
View company
DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases.
View company